A Double-blind, Randomized, Parallel Design Two Center Study to Compare the Effect of Vorapaxar vs. Placebo on Lower Extremity Vein Graft Maturation, Remodeling, and Function
Withdrawn prior to enrolment
Phase of Trial: Phase IV
Latest Information Update: 29 Jan 2018
At a glance
- Drugs Vorapaxar (Primary)
- Indications Peripheral arterial disorders
- Focus Pharmacodynamics
- 23 Jan 2018 Status changed from not yet recruiting to withdrawn prior to enrolment as could not secure adequate medication
- 13 Sep 2017 Planned initiation date changed from 1 Aug 2017 to 1 Oct 2017.
- 08 Aug 2017 Planned initiation date changed from 1 Dec 2016 to 1 Aug 2017.